House Amendment 427 to House Bill 3055
116th Congress(2019-2020)
An amendment numbered 101 printed in Part B of House Report 116-119 to prevent funds from being used to finalize, implement, or enforce the draft guidance issued by the Food and Drug Administration in December of 2017 titled Drug Products Labeled as Homeopathic: Guidance for FDA Staff and Industry.
Active
Withdrawn on Jun 20, 2019
Origin Chamber
House
Type
Amendment
Amendment
A proposed change to a pending text (e.g., a bill, resolution, another amendment, or a treaty [or an associated resolution of ratification]).
Amendment Number
427
Congress
116
Sort by most recent
06/20/2019
By unanimous consent, the Biggs amendment was withdrawn. (consideration: CR H4944)
06/20/2019
Amendment (A041) offered by Mr. Biggs. (consideration: CR H4943-4944; text: CR H4943)
06/20/2019
House amendment offered
Nov 21, 2019
Became Public Law 116-69
1
Sponsorship
Public Record
Record Updated
Dec 29, 2021 3:15:25 AM